CVS Health Corp vs United Microelectronics Corp — how do they compare? CVS Health Corp trades at $86.01 (market cap $112.29B), while United Microelectronics Corp trades at $22.91 (market cap $58.02B). The key difference: CVS Health Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and United Microelectronics Corp for 42 Days on average.
| CVS | UMC | |
|---|---|---|
Market Cap | $112.29B | $58.02B |
Volume | 7,763,676 | 11,897,809 |
Sector | Health | Technology |
52-Week High | $110.60 | $28.02 |
52-Week Low | $70.08 | $7.02 |
Typical Hold Time | 83 Days | 42 Days |
Enterprise Value | $174.64B | $55.10B |
Dividend Yield | 3.03% | 1.76% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
United Microelectronics (UMC) trades at $23.31, up 0.52% with a bullish technical signal despite mixed moving averages. The company shows strong profitability with 32.75% net income margin and 21.03% ROE, though revenue growth has slowed from 2022 peaks. Recent earnings beats and positive 2026 projections suggest operational strength, while analyst consensus remains cautious with 53% hold ratings.
UMC presents a mixed outlook with strong fundamentals offset by valuation concerns. The stock's 250% annual gain creates near-term resistance, while projected 2026 earnings growth of 103% offers upside potential. Key risks include semiconductor cyclicality and AI spending volatility, requiring careful position sizing despite intrinsic value estimates near $29.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →